Selected article for: "block de novo infection and de novo infection"
Author: Hsu, Shih-Hsien; Yeh, Ming-Lun; Wang, Shen-Nien
Title: New Insights in Recurrent HCV Infection after Liver Transplantation
  • Document date: 2013_4_23
    • ID: 0hbeso65_45
    Snippet: In addition to cell surface expressed host factors, HCV internalization and fusion are complex processes that also offer several targets for antivirals. A recent study demonstrated that long phosphorothioate oligonucleotides (PS-ON) inhibited HCV internalization without affecting viral binding and replication [117] . The human liver-chimeric Alb-uPA/SCID mouse model also showed that PS-ON block de novo HCV infection. These data shed light on the .....
    Document: In addition to cell surface expressed host factors, HCV internalization and fusion are complex processes that also offer several targets for antivirals. A recent study demonstrated that long phosphorothioate oligonucleotides (PS-ON) inhibited HCV internalization without affecting viral binding and replication [117] . The human liver-chimeric Alb-uPA/SCID mouse model also showed that PS-ON block de novo HCV infection. These data shed light on the promise of PS-ON as future clinical solution.

    Search related documents:
    Co phrase search for related documents
    • cell surface and complex process: 1, 2, 3, 4, 5, 6, 7, 8
    • cell surface and HCV internalization: 1
    • cell surface and host factor: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • cell surface and light shed: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14
    • clinical solution and light shed: 1
    • complex process and host factor: 1, 2
    • complex process and light shed: 1, 2, 3, 4, 5, 6
    • fusion HCV internalization and HCV internalization: 1